MedTrace Logo

Dexamethasone for PENG Block in Total Hip Arthroplasty

NCT06470139 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-03-24

No results posted yet for this study

Summary

Effect of adding Dexamethasone to Periarticular Nerve Group Block in Patients undergoing Total Hip Arthroplasty

Conditions

  • Hip Osteoarthritis
  • Hip Arthropathy
  • Hip Pain Chronic

Interventions

DRUG

Ropivacaine 0.2% Injectable Solution

20ml 0.2% Ropivacaine + 2.0ml 0.9% NaCl

DRUG

Ropivacaine 0.2% Injectable Solution + 4mg Dexamethasone

20ml 0.2% Ropivacaine + 4mg Dexamethasone

Sponsors & Collaborators

  • Poznan University of Medical Sciences

    lead OTHER

Principal Investigators

  • Malgorzata Domagalska, M.D. Ph.D. · Poznań University of Medical Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-13
Primary Completion
2025-01-15
Completion
2025-02-10

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06470139 on ClinicalTrials.gov